Cantor Fitzgerald increased its price target on Eli Lilly and Company stock.
2 reports, 2 independent
Updated Oct 18
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald increased its price target on Eli Lilly and Company stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.TD Waterhouse increased its stake in Eli Lilly shares alongside Cantor Fitzgerald's target price raise.1 source
Cantor Fitzgerald raised the price target for Eli Lilly and Company.1 source
Keep exploring
Part of
Analyst coverage is influencing stock price targets for companies including Bank of America, Eli Lilly and Company, Leerink partners, and Cantor Fitzgerald.Also in this story
- Market developments on July 25, 2026, involving Eli Lilly and Company, Cantor Fitzgerald, and filings with the SEC.
- Bank of America and Citigroup issued buy ratings and raised price targets on July 18, 2026.
- Copeland Capital Management reduced its stake in Eli Lilly and Company shares.
- Berenberg Bank and Leerink Partners raised price targets for Eli Lilly and Company on July 8, 2026.
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Cantor Fitzgerald lowered its price target on MARA stock on October 21, 2026.
- Analyst provides a high price target for Viking Therapeutics stock.
- Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.
- Analyst firms issued price targets and ratings involving Benchmark, Booking Holdings, and Cantor Fitzgerald.
- Cantor Fitzgerald raised its price target and gave an overweight rating for SOL Strategies Inc. on October 11, 2026.